...
首页> 外文期刊>Journal of nanoscience and nanotechnology >Clinical Study of Styping Detection of Human Papillomavirus (HPV) Infection with Microarray from Paraffinembedded Specimens of Cervical Cancer and Precursor Lesions
【24h】

Clinical Study of Styping Detection of Human Papillomavirus (HPV) Infection with Microarray from Paraffinembedded Specimens of Cervical Cancer and Precursor Lesions

机译:宫颈癌石蜡标本标本微阵列检测人乳头瘤病毒(HPV)感染的临床研究

获取原文
获取原文并翻译 | 示例

摘要

The prevalence and type distribution of human papillomavirus (HPV) in cervical cancer and cervical intraepithelial neoplasia (CIN) in Jiangsu, China was investigated. A total of 93 cases with cervical cancer and 176 CINII-III tissue samples were obtained from women undergoing biopsy or surgery. The 1047 exfoliated cervical cell samples were collected with cervical brush in physical examination women. HPV DNA and typing were examined by polymerase chain reaction (PCR) and gene-chip. The results showed that HPV DNA was detected in 82 cases with cervical cancer (88.17%), HPV 16 being detected in 65 (69.89%) cases, HPV 18 in 12 (12.90%) cases, HPV 33 in 10 (10.75%) cases, HPV 31 in 4 (4.30%) cases, and HPV 45 in 3 (3.23%) cases. HPV DNA was detected in 154 cases with CINII-Ill (87.50%), HPV 16 being detected in 92 (52.27%) cases, HPV 18 in 50 (28.41%) cases, HPV 33 in 25 (14.21%) cases, HPV 58 in 25 (14.21%) cases, and HPV 31 in 20 (11.36%) cases. About 20.43% cervical cancer and 38.64% CINII-III specimens exhibited multiple infections (p < 0.01). The total positive rate, single infection and mixed infection rate of the CINII-Ill and SCC group all had a significant difference (p < 0.05) when compared with the normal cells group. The total positive rate, single infection rate and mixed infection rate of CINII-Ill group did not show significant difference (p > 0.05) when compared with SCC group. CINII-Ill and SCC had all intimate relation with HPV infection. The high prevalence of HPV 16, 18, 33, 31 and 58 in Jiangsu (China) deserves more attention, as it has important implications for the successful use of HPV vaccine and choice of diagnostic methods.
机译:研究了江苏省宫颈癌和宫颈上皮内瘤变(CIN)中人乳头瘤病毒(HPV)的患病率和类型分布。从接受活检或手术的妇女中总共获得了93例宫颈癌病例和176份CINII-III组织样本。体检妇女用宫颈刷收集1047个脱落的宫颈细胞样品。 HPV DNA和分型通过聚合酶链反应(PCR)和基因芯片检查。结果显示,在82例宫颈癌中检出HPV DNA(88.17%),在65例(69.89%)中检出HPV 16,在12例(12.90%)中检出HPV 18,在10例(10.75%)中检出HPV 33。 ,4例(4.30%)的HPV 31和3例(3.23%)的HPV 45。在154例CINII-III中检出HPV DNA(87.50%),在92例中检出HPV 16(52.27%),在50例中检出HPV 18(28.41%),在25例中检出HPV 33(14.21%),HPV 58 25例(14.21%),HPV 31例20(11.36%)。约20.43%的宫颈癌和38.64%的CINII-III标本表现出多重感染(p <0.01)。与正常细胞组相比,CINII-III和SCC组的总阳性率,单次感染和混合感染率均具有显着差异(p <0.05)。与SCC组相比,CINII-Ill组的总阳性率,单次感染率和混合感染率没有显着差异(p> 0.05)。 CINII-Ill和SCC与HPV感染都息息相关。在中国江苏省,HPV 16、18、33、31和58的高流行率值得关注,因为它对成功使用HPV疫苗和选择诊断方法具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号